About this trial
The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.
Eligibility criteria
Qualifiers
Aged between 18-80 years
Traumatic and non-traumatic etiology
Para- and tetraplegic SCI
Complete and incomplete SCI
Disqualifiers
Inability to follow study instructions
Pregnancy
Medically manifested psychological disorder
Medical condition affecting the peripheral and/or central nervous system other than the desired experimental condition (e.g., additional peripheral neuropathy in the SCI cohort)
Trial design
Treatments tested in this trial
- Neurophysiology
- Cardiovascular test
- Experimental pain paradigms
- Quantitative sensory testing
- Clinical pain phenotype
- Pupillometry
Treatment groups
Sponsors and collaborators
University of Zurich
Lead sponsor
Swiss National Science Foundation
Collaborator